Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
India s largest pharmaceutical company, Piramal Pharma Limited, has announced its financial results for the second quarter (Q2 and half year (H1) ending 30th September 2023, which includes a 7% increase in revenue from Operation and 15% YoY.
Source: prnewswire.comPublished on 2023-10-28
Related news
- ARGAN published its new ESG strategy and has set ambitious
- EQS - Adhoc : Dexus Finance Pty Limited : Update on Collimate Capital acquisition - adhoc - Brsennachrichten
- Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
- Crestwood Equity Partners ( CEQP ) Q4 2022 Earnings Call Transcript
- Piramal Pharma Limited Announces Consolidated Results for Q1FY24
- PwC announces record global revenues of $50 billion New Business Ethiopia
- Refugee Integration Insights Publishes New Ranking of Top 50 Corporations Based on Their Contribution to Refugee Economic Integration
- Meehan Crist Is it OK to have a child ? LRB 23 February 2020
- Shell , Exxon , and BP reverse on climate amid record profits
- Enbridge : ( 296 KB ) | MarketScreener
- Top Oil Exporter Saudi Arabia , Led By The Crown Prince And New Prime Minister , Is Greening Up .
- 17 Most Valuable Furniture Companies In The World
- Made for TV : The SEC Regulatory Posture on Climate Risk | Cadwalader , Wickersham & Taft LLP
- More airlines want to limit climate change with sustainable fuels , not carbon offsets